Furthermore, IL-4 and IL-10 restrain IFN-γ production and impair cytotoxic cell-mediated anti-tumor immunity, suggesting that an increased shift from Th1 cells to Th2 cells promotes tumor progression and immunosuppression (31–34). The gene discussed is IFNG; the disease is neoplasm.